United States · FDA National Drug Code directory
Raloxifene Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-057_6c80d57b-e265-43cb-a781-6299ea73dccf
- Product NDC
- 65162-057
- Form
- TABLET, FILM COATED
- Composition / generic term
- Raloxifene Hydrochloride
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160120
- Source listing expiry
- 20271231
Source-listed ingredients
- RALOXIFENE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (65162-057-03) · 65162-057-03
- 90 TABLET, FILM COATED in 1 BOTTLE (65162-057-09) · 65162-057-09
- 100 TABLET, FILM COATED in 1 BOTTLE (65162-057-10) · 65162-057-10
- 1000 TABLET, FILM COATED in 1 BOTTLE (65162-057-11) · 65162-057-11
- 2000 TABLET, FILM COATED in 1 BOTTLE (65162-057-33) · 65162-057-33
- 500 TABLET, FILM COATED in 1 BOTTLE (65162-057-50) · 65162-057-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →